The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccrol Gp Regulatory News (ACRL)

Share Price Information for Accrol Gp (ACRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.50
Bid: 38.50
Ask: 38.70
Change: -0.20 (-0.52%)
Spread: 0.20 (0.519%)
Open: 38.60
High: 38.70
Low: 38.50
Prev. Close: 38.70
ACRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of highly scalable wet wipes business

9 Apr 2021 07:00

RNS Number : 9032U
Accrol Group Holdings PLC
09 April 2021
 

9 April 2021

 

ACCROL GROUP HOLDINGS PLC("Accrol", the "Company" or the "Group")

AIM: ACRL

 

ACQUISITION OF HIGHLY SCALABLE WET WIPES MANUFACTURER

 

Accrol Group, one of the UK's leading independent tissue converters, is pleased to announce that the Group has completed the acquisition of John Dale Limited ("John Dale"), a highly scalable flushable and biodegradable wet wipes business, for a total cash consideration of £3.9 million, funded from the Group's existing cash reserves.

 

Acquisition rationale

 

The acquisition of John Dale is a strategic move into high growth products within the wet wipes segment of the tissue market, providing a well invested platform on which to build a sizeable business.

 

Highlights

 

· John Dale has a long-established and unrivalled reputation as a privately-owned manufacturer of high quality own branded and private label wet wipes and facial tissues for the UK retail market

 

· Accrol and John Dale share several customers, but John Dale also brings a number of significant new accounts into the Group

 

· The product range includes flushable and biodegradable moist toilet wipes, anti-bacterial and anti-viral wipes, facial cleansing wipes, baby and toddler wipes and feminine hygiene wipes

 

· The addition of incremental volume to the Accrol facial tissue business will serve to leverage the Group's existing production facility in Blackburn

 

The business currently operates a single daily shift, five days a week, from its owned premises in Flint, North Wales, which is currently generating annualised revenue of c.£6.0 million and EBITDA (normalised) of c.£0.6 million.

 

Following acquisition, Accrol's primary areas of focus will be the expansion of the anti-bacterial and anti-viral wet wipe ranges and optimisation of production facilities.

 

The acquisition includes the 47,000 sq.ft. property from which the business operates. Both the business and the property were purchased from John and Pauline Dale.

 

Dan Wright, Executive Chairman of Accrol, said:

 

"I am delighted to announce the purchase of the John Dale business in Wales. A move into the attractive wet wipes' segment has been on our radar for some time; as a natural extension of our product range and wholly in line with our growth strategy across the household products category. It was essential, however, for us to find a business with a disruptive and environmentally friendly product which we could scale through organic investment. John Dale fits our criteria for growth - quality of product and market positioning, operating excellence in its asset base, and the optimisation of our distribution strengths. It gives Accrol a ready-made platform on which to build a sizeable wet wipes operation and presents an unmissable opportunity for us to compound shareholder value."

 

Gareth Jenkins, CEO of Accrol added:

 

"John Dale is an excellent business, with three modern wet wipe machines, which are significantly under-utilised. The UK wet wipe market is valued at £0.5bn. We are confident that, with our wide customer base, market and operational know-how and a modest investment in additional machine assets, we can scale this business significantly, while generating strong margins, over the next two to three years. The slack within the property and working capital assets of the business will fund much of this growth and accelerate financial returns."

 

 

For further information, please contact:

Accrol Group Holdings plc

Dan Wright, Executive Chairman

Via Belvedere Communications

Gareth Jenkins, Chief Executive Officer

Zeus Capital Limited (Nominated Adviser & Broker) 

Dan Bate / Jordan Warburton

Tel: +44 (0) 161 831 1512

Dominic King / John Goold

Tel: +44 (0) 203 829 5000

Liberum Capital Limited (Joint Broker)

Tel: +44 (0) 20 3100 2222

Clayton Bush / Edward Thomas

Belvedere Communications Limited

Cat Valentine

Tel: +44 (0) 7715 769 078

Keeley Clarke

Tel: +44 (0) 7967 816 525

Llew Angus

Tel: +44 (0) 7407 023 147

accrolpr@belvederepr.com

 

Overview of Accrol

 

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls and facial tissues to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisition of a state-of-the-art tissue converter based in Leicester, the Group now operates from five sites, including four in Lancashire, which generate revenues totalling c.16% of the £1.7bn UK retail tissue market.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQFZGGDNRFGMZM
Date   Source Headline
13th May 202410:46 amRNSForm 8.3 - Accrol Group Holdings Plc
10th May 20242:16 pmRNSForm 8.3 - Accrol Group Holdings PLC
10th May 20241:32 pmPRNForm 8.3 - Accrol Group Holdings plc
9th May 202412:58 pmPRNForm 8.3 - Accrol Group Holdings plc
9th May 202410:47 amRNSForm 8.3 - Accrol Group Holdings Plc
9th May 20247:49 amGNWForm 8.5 (EPT/RI) - Accrol Group Holdings Plc
8th May 20245:15 pmRNSTR-1
8th May 20243:04 pmPRNForm 8.3 - Accrol Group Holdings plc
8th May 202412:00 pmRNSForm 8.5 (EPT/RI) - Accrol Group Holdings plc
8th May 202410:57 amRNSForm 8.3 - Accrol Group Holdings Plc
8th May 20248:04 amGNWForm 8.5 (EPT/RI) - Accrol Group Holdings Plc
7th May 20243:27 pmRNSForm 8.3 - Accrol Group Holdings PLC
7th May 20241:11 pmRNSForm 8.3 - ACCROL GROUP HOLDINGS PLC
7th May 202411:13 amGNWForm 8.5 (EPT/RI) - 25.04.2024 AMENDED - Accrol Group Holdings Plc
7th May 20249:18 amRNSForm 8.3 - Accrol Group Holdings Plc
7th May 20248:56 amGNWForm 8.5 (EPT/RI)
3rd May 20243:25 pmRNSForm 8.3 - ACCROL GROUP HOLDINGS PLC
3rd May 20242:42 pmRNSIncreased and Final Offer
3rd May 20241:55 pmPRNForm 8.3 - Accrol Group Holdings Plc
2nd May 20243:25 pmRNSForm 8.3 - ACCROL GROUP HOLDINGS PLC
2nd May 20241:42 pmRNSForm 8.3 - Accrol Group Holdings plc
1st May 20243:25 pmRNSForm 8.3 - ACCROL GROUP HOLDINGS PLC
1st May 20243:11 pmRNSForm 8.3 - ACCROL GROUP HOLDINGS PLC
1st May 202410:05 amRNSForm 8.3 - Accrol Group Holdings Plc
1st May 20249:45 amGNWForm 8.5 (EPT/RI) - Accrol Group Holdings Plc
30th Apr 20244:40 pmRNSForm 8.3 - Accrol Group Holdings plc
30th Apr 20243:25 pmRNSForm 8.3 - ACCROL GROUP HOLDINGS PLC
30th Apr 202410:33 amRNSForm 8.3 - Accrol Group Holdings PLC
30th Apr 202410:01 amRNSForm 8.3 - Accrol Group Holdings Plc
30th Apr 20248:56 amGNWForm 8.5 (EPT/RI) - Accrol Group Holdings Plc
29th Apr 20243:25 pmRNSForm 8.3 - ACCROL GROUP HOLDINGS PLC
29th Apr 20247:52 amGNWForm 8.5 (EPT/RI) - Accrol Group Holdings Plc
26th Apr 20243:27 pmRNSForm 8.3 - Accrol Group Holdings PLC
26th Apr 20243:25 pmRNSForm 8.3 - ACCROL GROUP HOLDINGS PLC
26th Apr 20249:45 amGNWForm 8.5 (EPT/RI) - Accrol Group Holdings Plc
26th Apr 20249:22 amRNSForm 8.3 - Accrol Group Holdings Plc
26th Apr 20247:44 amPRNForm 8.3 - Accrol Group Holdings Plc
25th Apr 20243:25 pmRNSForm 8.3 - ACCROL GROUP HOLDINGS PLC
25th Apr 20241:56 pmPRNForm 8.3 - Accrol Group Holdings plc
25th Apr 202412:43 pmRNSTR-1
25th Apr 20249:16 amRNSForm 8.3 - Accrol Group Holdings plc
25th Apr 20248:27 amGNWForm 8.5 (EPT/RI) - Accrol Group Holdings Plc
23rd Apr 20243:27 pmRNSForm 8.3 - Accrol Group Holdings PLC
23rd Apr 20243:25 pmRNSForm 8.3 - ACCROL GROUP HLDGS PLC
23rd Apr 20241:40 pmRNSForm 8.3 - Accrol Group Holdings PLC
23rd Apr 20248:09 amGNWForm 8.5 (EPT/RI) - Accrol Group Holdings Plc
22nd Apr 20243:27 pmRNSForm 8.3 - Accrol Group Holdings PLC
22nd Apr 20243:25 pmRNSForm 8.3 - ACCROL GROUP HLDGS PLC
22nd Apr 20242:59 pmPRNForm 8.3 - Accrol Group Holdings plc
22nd Apr 20242:40 pmRNSForm 8.3 - Accrol Group Holdings PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.